The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
I do believe that PH are part of the problem, they are spreading the word but are encouraging their investors to place low ball offers which are being managed by the MM's, aided by weak and fearful investors, suitably aided by those that spread fear amongst other things (paid trolls).
There are only a certain amount of weak holders, most shares are held long term and by people that have faith in the product line up. In the interim the MM's will take advantage by any means possible. Hold tight, don't set your stop losses low, in fact set them exceptionally high to protect your assets and wait for the inevitable rise.
GLA
Now that we have entered clinical trials with our latest drug candidate, and we have 737 which is ready for Phase 3/or combo therapy with other drugs, surely now is the time to be invested and hold.
Is it really worth the risk in trading or waiting? it's now up to each individual to cement their strategy, I'm all in now until the end.
GLA
Just my opinion guys but I have not yet seen a company in the african continent that manages to do anything on time, and i can list many as proof. Having said that AEX are in the best position that I have ever seen. It's not a case of if t will happen, it's a case of when (how long is a piece of string?). Many LT shareholders will know this and be prepared to wait this out, I think the next 12 months could be huge (im happy to wait and see!).
GLA
Mine was in a standard saver, 0.85%, shoddy! Hence the reason for move. People will vote with their feet as times get tough due to the cost of living. We are certainly in a mess.
All this to the detriment of loyal customers and shareholders, I've just moved all of my savings to another bank due to poor interest rates being offered at Lloyds. Additionally the shareholder returns are not at the level that they should be. While I acknowledge that these don't go hand in hand with each other, at least one increase would be appreciated.
There is too much smoke and too many mirrors now and I have lost faith in this and other PL ventures. Shareholders have gained nothing and with further diversification it seems like a cash cow for PL and his tribe. I'm now out and will not be investing in anything that PL is involved in going forward.
GL to those who remain.
Aber, its always the same, and it's not what it may seem. they would not be giving 126 to sell as there is nothing in it for them, they have increased the spread to enable such manipulation of the market. Todays rise is also within the scope of the wider spread, and so it continues.....
on the plus side we are still moving forward with huge positive steps, these i'm sure aren't going un-noticed. We are now less than a year away from trials in patients and as time goes by the value of the product increases significantly.
GLA
BG, now we are talking about Tanzania, how many years have we been waiting? Nothing ever happens quickly even with ARA/Zubs onboard!
All I can say is that it will happen when it happens, and that advice is no use at all!!!!
The RNS today is obviously great news and SAR has huge life changing potential, however the reality is that the SP is still below consolidation level. Just saying that it is wise to consider the bigger picture.
GLA and have a great bank holiday/coronation weekend.
SOG, interesting to note that our CHK1 compares favourably against other competitor CHK1's. While not effective as a monotherapy, it is effective as a combo with less adverse events. It does more in combo and enables smaller doses which is better for patients involved. Much to look forward too!